HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

United States Microbial Transglutaminase Market Size & Outlook, 2025-2033


United States Microbial Transglutaminase Market Insights

  • As per Reed Intelligence insights, the United States Microbial Transglutaminase Market stood at USD 35.06 Million in 2024 and is anticipated to grow to USD 82.3 Million by 2033.
  • The United States market is expected to advance at a CAGR of 9.94% from 2026 through 2033.
  • In 2024, Streptomyces Mobaraense accounted for the highest share of the By Source market size.
  • During the forecast period, Streptoverticillium Hygroscopicus is set to register the highest growth, making it the most lucrative By Source segment.

Other Key Findings


  • As of 2024, United States held 25.68% of the global Microbial Transglutaminase Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Microbial Transglutaminase Market.
  • In North America, United States is expected to lead the regional Microbial Transglutaminase Market size by 2033.
  • United States will remain the fastest-growing market in North America, reaching USD 82.26 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 35.06 Million
Market Size In 2033 USD 82.3 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 9.94% (2025-2033)
Segmnetation Covered
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports